Iran’s Health Ministry said in a statement that the country’s COVID-19 fatalities and cases stood at 78 and 3,228, respectively, from Wednesday to Thursday.
The total COVID-19 death toll and cases since the beginning of the outbreak in the country in late February 2020 stand at 130,524 and 6,147,872.
It said 3,169 patients are in critical condition, and 529 new ones have been hospitalized.
According to the statement, 5,950,425 people have so far either recovered from the disease or have been discharged from hospitals, and 39,739,512 diagnostic tests have been carried out in the country.
The total number of administered vaccine doses stands at 109,387,244, of which 58,489,565 have been given to people as the first dose, and 48,926,450 as the second one.
In addition, 1,971,229 have received their third dose.
Two cities in the country are currently coded red (very high-risk) in terms of the coronavirus spread, while nine cities are in the orange zone (high-risk). The number of yellow (medium-risk) and blue (low-risk) cities are 153 and 284, respectively.
Since the outbreak, Iran has grappled with five waves of COVID-19 infections, with the last one being the greatest and deadliest of all and troubling the country until a few weeks ago. Sparked mainly due to the spread of the Delta variant, the wave caused the country see record high daily deaths and cases of over 700 and 40,000, respectively.
Although the wave has subsided thanks to the increased pace of the public vaccination process, authorities constantly warn against the start of a new wave given the spread of the new strain of the coronavirus, known as Omicron, calling for full compliance with the health protocols.
Iran’s public vaccination has gained greater momentum over the past few months on the back of an increase in imports and domestic production. The country has produced a number of COVID jabs domestically and received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN).